ASTH
Get informed when a big investor buys or sells
+ FollowUndervalued by 133.9% based on the discounted cash flow analysis.
| Market cap | $1.87 Billion |
|---|---|
| Enterprise Value | $1.47 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.46 |
| Beta | 0.99 |
| Outstanding Shares | 48,853,678 |
| P/E Ratio | 60.79 |
|---|---|
| PEG | 52.54 |
| Price to Sales | 0.45 |
| Price to Book Ratio | 3.44 |
| Enterprise Value to Revenue | 0.35 |
| Enterprise Value to EBIT | 242.26 |
| Enterprise Value to Net Income | 47 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.11 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
apollo medical holdings, inc., a physician-centric technology-powered healthcare management company, provides medical care services. the company, leveraging its proprietary population health management and healthcare delivery platform, o...
This is a critical committee as it controls taxation, trade, and entitlement spending, including the financing and reimbursement policies for Medicare and Medicaid. These policies directly impact Astrana Health's revenue streams and profitability from its publicly insured patient base.
This committee directly allocates discretionary federal spending. Its subcommittees determine the precise funding for agencies like HHS and CMS, which dictate reimbursement rates and funding levels for Medicare and Medicaid, primary revenue sources for Astrana Health.
This committee directly regulates health policy, affects the regulatory environment for healthcare delivery, and oversees labor laws. These aspects directly impact Astrana's operational costs, its 'physician network', and the overall environment for its healthcare management services.